These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins. Rechler MM, Zapf J, Nissley SP, Froesch ER, Moses AC, Podskalny JM, Schilling EE, Humbel RE. Endocrinology; 1980 Nov; 107(5):1451-9. PubMed ID: 6159199 [Abstract] [Full Text] [Related]
5. Effects of a single cleavage in insulin-like growth factors I and II on binding to receptors, carrier proteins and antibodies. Jansen J, van Buul-Offers SC, Hoogerbrugge CM, Van Den Brande JL. Biochem J; 1990 Mar 01; 266(2):513-20. PubMed ID: 2156497 [Abstract] [Full Text] [Related]
7. Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity. Clemmons DR, Cascieri MA, Camacho-Hubner C, McCusker RH, Bayne ML. J Biol Chem; 1990 Jul 25; 265(21):12210-6. PubMed ID: 1695626 [Abstract] [Full Text] [Related]
17. The binding of insulin-like growth factor II to the erythroleukemia cell line K562. Tally M, Tang XZ, Enberg G, Hall K. Biosci Rep; 1984 Dec 25; 4(12):1071-7. PubMed ID: 6099156 [Abstract] [Full Text] [Related]
18. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture. Myal Y, Shiu RP, Bhaumick B, Bala M. Cancer Res; 1984 Dec 25; 44(12 Pt 1):5486-90. PubMed ID: 6093996 [Abstract] [Full Text] [Related]